Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%

Trials by Status

recruiting125%
completed375%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

NCT05935384
completed

Achieving Value in Cancer Diagnostics: Blood Versus Tissue Molecular Profiling - a Prospective Canadian Study

NCT03576937
completed

Noninvasive vs. Invasive Lung Evaluation

NCT03615443
completed

Spanish Lung Liquid vs. Invasive Biopsy Program (SLLIP)

NCT03248089

Clinical Trials (4)

Showing 4 of 4 trials
NCT05935384

SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

Recruiting
NCT03576937

Achieving Value in Cancer Diagnostics: Blood Versus Tissue Molecular Profiling - a Prospective Canadian Study

Completed
NCT03615443

Noninvasive vs. Invasive Lung Evaluation

Completed
NCT03248089

Spanish Lung Liquid vs. Invasive Biopsy Program (SLLIP)

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4